TRV NYSE Week ended 24 Jul 2026

Weekly Investor Report

The Travelers Companies Inc · Financial Services · Insurance - Property & Casualty

Open interactive chart View report data Download investor PDF
Latest close 387.3 USD
5.0% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 27.2% above the Trend Line and sits at 98.7% of its 52-week range. The latest completed week returned 5.0%, after a 18.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. Options positioning is mixed with 38/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: price is close to its 52-week high; earnings are due in 78d.

Setup score 85 out of 100
Latest Close 387.3 USD 24 Jul 2026
1W Return 5.0% latest completed week
4W Return 18.3% short-term follow-through
12W Return 27.6% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 98-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 5.0% Latest completed week; four-week move 18.3%. Indicator stack 100/99 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 62.55% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 38/100 conviction; expected move 4.9%. News sentiment 56/100 49 relevant articles in the latest sentiment read. Event risk 78d Next report is scheduled for 15 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 27.2% above the Trend Line and sits at 98.7% of its 52-week range. The latest completed week returned 5.0%, after a 18.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8712-week average 0.76

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.87Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 18.3% over four weeks, 27.6% over 12 weeks, and 50.7% over one year. The current trend has remained active for 98 consecutive weeks.

Performance by holding period

1W5.0%
4W18.3%
12W27.6%
26W40.5%
52W50.7%
Active trend streak98 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.66Latest activity-pressure read.
Pressure change236.8%Four-week change in activity pressure.
Leadership23.12Latest relative-leadership reading.
RS change239.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength95/100Blend of value, momentum, and quality. Underlying universe rank 6; rank 1 is best.
Value90/100Relative valuation strength. Underlying universe rank 11; rank 1 is best.
Quality71/100Profitability and accounting quality. Underlying universe rank 30; rank 1 is best.
Momentum83/100Medium-term price momentum. Underlying universe rank 18; rank 1 is best.
Growth81/100Revenue and earnings growth. Underlying universe rank 20; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework90/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
9.7x
Price divided by trailing earnings.
Price / sales
1.6x
Market value relative to trailing revenue.
EV / EBITDA
7.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
15.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
34.7%
Gross profit retained from each unit of revenue.
Operating margin
22.0%
Operating profit retained from revenue.
Free-cash-flow margin
28.0%
Free cash flow generated from revenue.
Return on invested capital
20.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.4%
Latest one-year revenue growth.
EPS growth
58.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
42.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.2%
Cash dividends relative to market value.
Buyback yield
6.6%
Net share repurchases relative to market value.
Shareholder yield
7.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

TRV shows mixed options pressure with a 38/100 conviction score, put-call volume ratio of 0.99, expected move of 4.9%, and Sharemaestro trend signal active.

Conviction38/100
Expected move4.9%
Put/call volume0.99
Pressure3
Speculation35
Volatility38
Trend agreement98
Open options detail
Insider activity7 / 13

7 acquisitions and 13 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 49 relevant articles.

19 positive · 28 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings78dNext report is scheduled for 15 Oct 2026; event risk rises as the date approaches.
Options expected move4.9%Nearest-chain priced movement where available.
52-week drawdown-0.5%Distance below the 52-week high.
13-week volatility3.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher18 of 268 weeks finished lower.
Best week+8.9%Week of 17 Jul.
Worst week-4.8%Week of 29 May.
Latest week+5.0%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains13
Flat weeks0
Modest losses7
Sharp losses1
Recent vol3.5%13-week weekly-return volatility.
Base vol2.9%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew2.6% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape85/100

Trend, activity pressure, participation, and risk combine to a 85/100 tape read.

 Indicator analysis64/100

Latest 12-week confirmation: trend 12/12, activity pressure 7/12, relative leadership 5/12.

Activity pressure 0.87; 3 reversal markers Next-Week ExpectancyPositive 62.55%

Next-week expectancy is positive with a 62.55% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors84/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 9 SVQF90/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 104.5 of 1006 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options60/100

TRV shows mixed options pressure with a 38/100 conviction score, put-call volume ratio of 0.99, expected move of 4.9%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 4.9% Sentiment56/100

Weighted news tone is neutral across 49 relevant articles.

The Travelers Companies, Inc. $TRV Shares Sold by Empire Financial Management Company LLC Insiders7 / 13

7 acquisitions and 13 disposals in the latest 180-day insider tape.

 Earnings78d

Next report is scheduled for 15 Oct 2026; event risk rises as the date approaches.

 Research flow3 items

2 recent research articles and 1 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026387.3 USD5.0%304.5 USD241.0 USD1.6623.1212.1MOn
17 Jul 2026369.0 USD8.9%301.3 USD239.6 USD1.6117.2411.7MOn
10 Jul 2026338.9 USD-1.0%298.7 USD238.3 USD1.326.397.2MOn
3 Jul 2026342.3 USD4.6%296.8 USD237.1 USD0.969.135.9MOn
26 Jun 2026327.4 USD6.4%294.7 USD236.0 USD0.496.8214.5MOn
19 Jun 2026307.8 USD1.1%293.4 USD234.9 USD-0.21-1.8512.3MOn
12 Jun 2026304.5 USD0.8%292.7 USD234.0 USD-0.34-2.167.9MOn
5 Jun 2026302.0 USD3.9%292.0 USD233.1 USD-0.50-2.527.1MOn
29 May 2026290.7 USD-4.8%291.2 USD232.3 USD-0.53-8.706.0MOn
22 May 2026305.2 USD2.2%290.3 USD231.5 USD-0.12-3.107.3MOn
15 May 2026298.5 USD0.6%289.1 USD230.6 USD0.03-4.637.3MOn
8 May 2026296.8 USD-2.2%287.7 USD229.8 USD0.24-5.215.2MOn
1 May 2026303.5 USD0.7%286.7 USD228.9 USD0.33-1.127.1MOn
24 Apr 2026301.5 USD0.6%286.0 USD228.1 USD0.08-1.058.5MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.